Traduire
Le projet EMBOBIO reçoit le prix de l’innovation AP-HM 2022
NEOSTEM : soigner l’encéphalopathie anoxo-ischémique du nouveau-né grâce à la thérapie cellulaire
Spreading safe, cheap embolization around the world
Le CERIMED, une plate-forme d’imagerie transversale, interdisciplinaire et fédératrice
R&D
Located on the Marseille-Timone Campus, CERIMED is an innovative multidisciplinary working environment opened to academics and SME for the development and validation of novel medical imaging techniques and protocols.
Services
CERIMED offers its equipments and knowledge in the form of a range of service offers for academics and industries. Each CERIMED department may contribute to development and validation of your innovative medical imaging techniques and protocols.
Training
Implement a transversal way of learning and training, meeting the various concerned disciplines (physics, biology, medicine, radiopharmacy, ...) and the industry, but also offer a theoretical and practical training to the medical imaging techniques.
Recent Posts
-
Symposium’23 Program
“Innovative drugs & health products,
imaging & theranostics agents –
cell & gene biotherapies”, March 17, 2023, 13:30 - 3e matinée Carnot Star “9-12 Recherche-Industrie” dédiée à l’Imagerie, 17 Mars 2023, 8h30
- FairEmbo en Afrique : “Ce médecin marseillais sauve des femmes avec des bouts de ficelle”
- Webinar: Discover Radiotheranostics in Nuclear Medicine (15 Sept. 2022)
- Le projet EmboBio, développé au CERIMED, a reçu le prix de l’innovation AP-HM 2022
Dernières Publications (5/333)
- Tolboom, N, Verger, A, Albert, NL, Brendel, M, Cecchin, D, Fernandez, PA et al.. EANM position paper: theranostics in brain tumours-the present and the future. Eur J Nucl Med Mol Imaging. 2023; :. doi: 10.1007/s00259-023-06425-8. PubMed PMID:37698647 .
- Albert, NL, Garrigue, P, Guillet, B, Burger, IA. Correction to: Highlights of the 35th EANM Annual Congress 2022, onsite edition in Barcelona, Spain: “FROM BARCELONA WITH LOVE”. Eur J Nucl Med Mol Imaging. 2023; :. doi: 10.1007/s00259-023-06419-6. PubMed PMID:37646835 .
- Cuny, T, Romanet, P, Goldsworthy, M, Guérin, C, Wilkin, M, Roche, P et al.. Cinacalcet reverses short QT interval in Familial Hypocalciuric Hypercalcemia type 1. J Clin Endocrinol Metab. 2023; :. doi: 10.1210/clinem/dgad494. PubMed PMID:37602721 .
- de la Fouchardière, C, Haissaguerre, M, Decaussin-Petrucci, M, Renaudin, K, Deschamps, F, Mirallié, E et al.. [French recommendations for malignant pheochromocytomas and paragangliomas by the national ENDOCAN-COMETE network]. Bull Cancer. 2023; :. doi: 10.1016/j.bulcan.2023.06.002. PubMed PMID:37573200 .
- Abellan Lopez, M, Hutter, L, Pagin, E, Vélier, M, Véran, J, Giraudo, L et al.. In vivo efficacy proof of concept of a large-size bioprinted dermo-epidermal substitute for permanent wound coverage. Front Bioeng Biotechnol. 2023;11 :1217655. doi: 10.3389/fbioe.2023.1217655. PubMed PMID:37560537 PubMed Central PMC10407941.